| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | RSI | United States | $11.57 | $1,134,428,000.00 | Buy | 13 | 2020 |
#2 | INVA | United States | $18.28 | $217,217,000.00 | Buy | 5 | 2000 |
#3 | CRMD | United States | $4.68 | $311,709,000.00 | Buy | 5 | 2009 |
#4 | ARR | United States | $10.94 | $0.00 | Buy | 6 | 2009 |
#5 | HL | United States | $12.51 | $645,957,000.00 | Buy | 10 | 2002 |
#6 | CDE | United States | $13.18 | $709,598,000.00 | Buy | 11 | 1994 |
#7 | FRST | United States | $14.13 | $0.00 | Strong Buy | 4 | 2006 |
#8 | BCRX | United States | $7.52 | $25,186,000.00 | Buy | 11 | 1995 |
#9 | DEC | United States | $13.08 | $1,829,142,000.00 | Strong Buy | 10 | 2022 |
#10 | NVAX | United States | $7.95 | $1,123,479,000.00 | Buy | 9 | 1996 |
#11 | ABX | United States | $6.66 | $235,237,636.00 | Buy | 6 | 2020 |
#12 | BKV | United States | $18.72 | $893,781,000.00 | Strong Buy | 11 | 2022 |
#13 | OOMA | United States | $17.53 | $114,490,000.00 | Strong Buy | 7 | 2015 |
#14 | MITK | United States | $16.70 | $45,390,000.00 | Strong Buy | 5 | 1995 |
#15 | BVS | United States | $10.61 | $568,087,000.00 | Strong Buy | 5 | 2016 |
#16 | ZVRA | United States | $9.39 | $106,470,000.00 | Strong Buy | 9 | 2015 |
#17 | DSP | United States | $11.31 | $344,201,000.00 | Strong Buy | 11 | 2021 |
#18 | UMH | United States | $13.95 | $261,754,000.00 | Buy | 9 | 1995 |
#19 | UPST | United States | $18.14 | $1,043,857,000.00 | Buy | 16 | 2020 |
#20 | MASS | United States | $9.39 | $56,197,000.00 | Strong Buy | 6 | 2020 |
#21 | OPRX | United States | $6.96 | $109,429,000.00 | Strong Buy | 6 | 2008 |
#22 | MCHB | United States | $14.10 | $49,728,000.00 | Buy | 4 | 2011 |
#23 | PGY | United States | $15.43 | $1,301,360,000.00 | Strong Buy | 11 | 2021 |
#24 | MNRO | United States | $10.07 | $1,157,176,000.00 | Buy | 5 | 1994 |
#25 | NMRK | United States | $10.18 | $3,294,024,000.00 | Buy | 7 | 2017 |
#26 | NEOG | United States | $10.91 | $870,400,000.00 | Buy | 4 | 1995 |
#27 | BODI | United States | $3.18 | $251,727,000.00 | Buy | 4 | 2020 |
#28 | OMDA | United States | $14.08 | $260,210,000.00 | Buy | 12 | 2025 |
#29 | ADNT | Ireland | $15.08 | $17,439,000,000.00 | Buy | 12 | 2016 |
#30 | ADTN | United States | $4.63 | $1,083,807,000.00 | Buy | 9 | 1996 |
#31 | PTEN | United States | $9.91 | $4,826,624,000.00 | Buy | 16 | 1995 |
#32 | AVNW | United States | $16.35 | $243,858,000.00 | Strong Buy | 8 | 2007 |
#33 | MBLY | Israel | $5.21 | $1,894,000,000.00 | Buy | 23 | 2022 |
#34 | CRSR | United States | $11.17 | $1,472,480,000.00 | Buy | 9 | 2020 |
#35 | PAYS | United States | $9.81 | $24,120,434.00 | Buy | 5 | 2020 |
#36 | QUBT | United States | $5.14 | $682,000.00 | Buy | 6 | 2019 |
#37 | UMAC | United States | $10.07 | $11,199,217.00 | Strong Buy | 9 | 2023 |
#38 | NLY | United States | $17.02 | $0.00 | Buy | 13 | 1997 |
#39 | ADEA | United States | $14.75 | $443,386,000.00 | Buy | 4 | 2020 |
#40 | SOUN | United States | $3.06 | $0.00 | Strong Buy | 6 | 2021 |
#41 | NUVB | United States | $3.92 | $62,902,000.00 | Strong Buy | 13 | 2020 |
#42 | CAI | United States | $19.93 | $812,033,000.00 | Buy | 14 | 2025 |
#43 | ACRS | United States | $3.39 | $1,683,000.00 | Strong Buy | 12 | 2015 |
#44 | DX | United States | $9.73 | $0.00 | Buy | 6 | 1994 |
#45 | LTRX | United States | $3.93 | $120,899,000.00 | Strong Buy | 6 | 2000 |
#46 | NHP | United States | $14.55 | $342,279,000.00 | Buy | 8 | 2012 |
#47 | CADL | United States | $5.40 | $125,000.00 | Strong Buy | 10 | 2021 |
#48 | BLZE | United States | $6.89 | $145,835,000.00 | Buy | 7 | 2021 |
#49 | MFA | United States | $5.74 | $0.00 | Buy | 7 | 1998 |
#50 | AOMR | United States | $5.24 | $0.00 | Buy | 6 | 2019 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $20 to Buy (November 18, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.